Dose Escalation Safety Study of MM-10-001 in Healthy Subjects
Phase 1
- Conditions
- Healthy
- Interventions
- Other: lentinanOther: placebo
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2008-05-13
- Lead Sponsor
- GlycaNova Norge AS
- Target Recruit Count
- 50
- Registration Number
- NCT00677027
- Locations
- 🇳🇴
Centre for clinical studies, Bergen, Paradis, Norway
© Copyright 2025. All Rights Reserved by MedPath